ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,658.00
0.32%
S&P 500
5,214.08
0.51%
US Dollar vs CAD
1.36835
0.04%
Bitcoin
63,306.22
0.41%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Virpax Pharmaceuticals Inc (VRPX)

  7. Virpax Pharmaceuticals Inc (VRPX) News

VRPX Virpax Pharmaceuticals Inc

2.49
0.13 (5.51%)
May 09 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Virpax Pharmaceuticals Inc VRPX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.13 5.51% 2.49 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.50 2.295 2.66 2.49 2.36
more quote information »

Recent News

Date Time Source Heading
4/30/202406:30BWVirpax Announces Results of Maximum Tolerated Dose Study for..
3/26/202406:30BWVirpax Pharmaceuticals Reports 2023 Year-End Results
2/27/202406:31BWVirpax Pharmaceuticals Announces Reverse Stock Split to..
2/27/202406:30BWVirpax Pharmaceuticals Announces Proposed Settlement of..
2/07/202406:30BWVirpax Pharmaceuticals Announces Preliminary Results of..
1/31/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/29/202306:30EDGAR2Form 8-K - Current report
12/29/202306:30BWVirpax Pharmaceuticals Announces Results of Special..
12/13/202307:30EDGAR2Form 8-K - Current report
12/07/202308:08EDGAR2Form DEF 14A - Other definitive proxy statements
12/07/202307:58EDGAR2Form 8-K - Current report
12/07/202307:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/21/202315:57EDGAR2Form PRE 14A - Other preliminary proxy statements
11/17/202306:30EDGAR2Form 8-K - Current report
11/17/202306:15EDGAR2Form 8-K - Current report
11/17/202306:10BWVirpax Pharmaceuticals Announces Notification from Nasdaq..
11/17/202306:00BW Virpax Pharmaceuticals Announces Leadership Transition
11/16/202315:51EDGAR2Form 8-K - Current report
11/15/202315:15BWVirpax Pharmaceuticals Reports 2023 Third Quarter Results..
11/15/202314:03EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/31/202307:58BWVirpax Pharmaceuticals Announces that Envelta™ Remains on..
10/12/202307:02BWVirpax Pharmaceuticals Announces Extension of CRADA with the..
10/11/202315:10EDGAR2Form 8-K - Current report
10/03/202308:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/02/202307:58BWGerald W. Bruce Appointed President and CEO of Novvae™..
9/27/202307:58BWVirpax Pharmaceuticals Announces Results of Probudur™ Dose..
9/26/202307:58BWVirpax Pharmaceuticals to Present at the LD Micro Main Event..
9/21/202312:35BWAltasciences von Virpax ausgewählt, um die Entwicklung eines..
9/21/202312:18BWAltasciences choisi par Virpax pour soutenir le..
9/21/202309:00BWAltasciences Chosen by Virpax to Support the Development of..
9/18/202306:58BWVirpax Pharmaceuticals Announces the Formation of Novvae™..
9/05/202308:28EDGAR2Form 8-K - Current report
9/05/202308:00BWVirpax Pharmaceuticals Updates on Litigation
8/28/202307:58BWVirpax® Pharmaceuticals to Present at H.C. Wainwright 25th..
8/16/202316:00EDGAR2Form 8-K - Current report
8/16/202316:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
8/14/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202308:05EDGAR2Form 8-K - Current report
8/14/202308:00BWVirpax Pharmaceuticals Reports 2023 Second Quarter Results..
8/10/202307:58BWVirpax Pharmaceuticals Files Provisional Patent Application..
7/26/202315:10EDGAR2Form 8-K - Current report
7/24/202306:00BWVirpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on..
7/13/202307:58BWVirpax Pharmaceuticals Files Provisional Patent Application..

Your Recent History

NASDAQ
VRPX
Virpax Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved